PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Wechsler, Lawrence
TI  - No Advantage for Percutaneous Closure of PFO versus Medical Therapy in Reducing Recurrent Neurological Events
DP  - 2011 Apr 01
TA  - MD Conference Express
PG  - 16--17
VI  - 11
IP  - 1
4099  - http://mdc.sagepub.com/content/11/1/16.short
4100  - http://mdc.sagepub.com/content/11/1/16.full
AB  - The CLOSURE I trial [NCT00201461] was conducted to determine if percutaneous patent foramen ovale closure using the STARFlex® Septal Closure System in combination with medical therapy, is superior to medical therapy alone to prevent recurrent ischemic neurological symptoms in patients with transient ischemic attack or ischemic stroke.